Kanti Rai MD

Professor of Medicine, Albert Einstein College of Medicine

LIJMC Dept of Med Hematology Oncology Chief270 05 76TH AvenueNew Hyde Park, NY 11040
Phone+1 718-470-7135
Fax+1 718-470-4250

Dr. Rai is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rai's full profile Already have an account?

Education & Training

North Shore University Hospital - Northwell HealthResidency, Occupational Medicine, 1960 - 1960
Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical CenterResidency, Pediatrics, 1958 - 1959
Lincoln Medical and Mental Health CenterInternship, Transitional Year, 1957 - 1958
Sawai Man Singh Medical CollegeClass of 1955

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NY State Medical License 1968 - 2028
American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2016-2017
CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2016-2017
America's Top Doctors Castle Connolly, 2006-2014

Clinical Trials

Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
COMPLETED
PHASE2
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
ACTIVE_NOT_RECRUITING
Campath Maintenance in Chronic Lymphocytic Leukemia
TERMINATED
NA

Publications & Presentations

PubMed

1 citations
CLL crosstalk with naïve T cells enhances the differentiation of IL-22-producing T cells and CLL -cell survival.
Gerardo Ferrer, Florencia Palacios, Pui Yan Chiu, Kelly Wong, Alberto Bueno-Costa
Leukemia. 2025-02-01
8 citations
Hairy cell leukemia variant and WHO classification correspondence Re: 5edition WHO classification haematolymphoid tumors: lymphoid neoplasms.
Michael Grever, Leslie Andritsos, Mirela Anghelina, Evgeny Arons, Versha Banerji
Leukemia. 2024-07-01
1 citations
BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on Mechanism.
Hyunjoo Lee, Shabirul Haque, Rashmi Gupta, Jonathan E Kolitz, Steven L Allen
Lymphatics. 2024-06-01

Abstracts/Posters

Gene Expression and Cytokine Analyses Identify Markers of Progression from CLL-like Monoclonal B-Cell Lymphocytosis to Chronic Lymphocytic Leukemia
Kanti R Rai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
CLL B Cells Develop Resistance to Ibrutinib By Reinvigorating the IL-4R - IL-4 Axis Blocked By BrutonÍs Tyrosine Kinase Inhibitors Including Acalabrutinib and Zanubrut...
Kanti R Rai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Deciphering the CXCL9-CXCL10-CXCL11/CXCR3 Axis in CLL-like Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia: A New Target for Immune Activation?
Kanti R Rai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Ibrutinib Treatment Reduces Myeloid Derived Suppressor Cell Numbers and Function in Chronic Lymphocytic Leukemia
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
CLL Intraclonal Fractions Defined By Time Since Cell Birth/Division Promote a Leukemia-Supportive, Immune-Tolerant Microenvironment By Distinct Mechanisms
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Extended Survival in CLL Patients Who Discontinued Idelalisib Because of Colitis Correlates with Higher Th17 Levels in Blood and Colon Tissue
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Other

Epidemiology and clinical manifestations of chronic lymphocytic leukemia
Rai KR, Keating MJ
http://www.uptodate.com/contents/epidemiology-and-clinical-manifestations-of-chronic-lymphocytic-leu
UpToDate, Wolters Kluwer Health - 2013-03-15
Overview of the complications of chronic lymphocytic leukemia
Rai KR, Keating MJ
http://www.uptodate.com/contents/overview-of-the-complications-of-chronic-lymphocytic-leukemia
UpToDate, Wolters Kluwer Health - 2013-03-22
Overview of the treatment of chronic lymphocytic leukemia
Rai KR, Keating MJ
http://www.uptodate.com/contents/overview-of-the-treatment-of-chronic-lymphocytic-leukemia
UpToDate, Wolters Kluwer Health - 2012-10-01

Press Mentions

Drug Duo May Be a Weapon Against a Common LeukemiaAugust 11th, 2019
Lymphoma Research Foundation's 2019 Swirl: Chicago Raises More Than $130,000June 5th, 2019
Management of Older Patients with Chronic Lymphocytic LeukemiaDecember 10th, 2017